Loading stock data…
Rapid Micro Biosystems, Inc. (RPID)
$1.22-0.09 (-6.87%)
Market ClosedLast close Sep 8
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Rapid Micro Biosystems, Inc. in the Healthcare sector is trading at $1.22 with a market capitalization of $86M. Wall Street consensus targets $6.67 (3 analysts), implying a +446.4% move over the next 12 months. The stock is currently near its 52-week low of $1.22, remaining 55.3% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 24 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply +446.4% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 24) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $8.05M↑ | $8.00M↓ | $11.28M↑ | $7.84M↑ | $7.26M |
| Gross Profit | $1.21M↑ | $371,000↑ | -$328,000↓ | $696,000↑ | $275,000 |
| Operating Income | -$12.32M↑ | -$13.85M↓ | -$12.21M↓ | -$11.37M↑ | -$12.15M |
| Net Income | -$12.92M↑ | -$14.28M↓ | -$12.50M↓ | -$11.51M↑ | -$11.86M |
Peer Comparison
JNJUNHPFE
Fundamentals
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switze...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$85.69M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.47
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-245.78%
Volume
Today's trading volume
310,807
Recent News
After Plunging 33.7% in 4 Weeks, Here's Why the Trend Might Reverse for Rapid Micro Biosystems (RPID)
Rapid Micro Biosystems (RPID) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Down 25.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Rapid Micro Biosystems (RPID)
The heavy selling pressure might have exhausted for Rapid Micro Biosystems (RPID) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Rapid Micro Biosystems (RPID) Q2 2026 Earnings Call Transcript
Record gross margins and 200th system milestone signal momentum toward profitability.
Rapid Micro Biosystems (RPID) Upgraded to Buy: What Does It Mean for the Stock?
Rapid Micro Biosystems (RPID) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Rapid Micro Biosystems, Inc. Q2 2026 Earnings Call Summary
Moby summary of Rapid Micro Biosystems, Inc.'s Q2 2026 earnings call